Related references
Note: Only part of the references are listed.Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
P. H. Schafer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis
Riichiro Abe et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
Giulia Tonel et al.
JOURNAL OF IMMUNOLOGY (2010)
Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model
Cecilia Rosada et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Significance of the S100A4 Protein in Psoriasis
John R. Zibert et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model
K. Stenderup et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Psoriasis: characterization of six different clinical phenotypes
Christiane Guinot et al.
EXPERIMENTAL DERMATOLOGY (2009)
Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model
Peter H. Kvist et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model
Maria Jakobsen et al.
MOLECULAR THERAPY (2009)
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
Roberta Caruso et al.
NATURE MEDICINE (2009)
FR255734, a humanized, Fc-silent, anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model
Siba P. Raychaudhuri et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one(Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined Immunodeficient mouse transplant model
Narasimharao Bhagavathula et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis
Curdin Conrad et al.
NATURE MEDICINE (2007)
Mouse models of psoriasis
Johann E. Gudjonsson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
In situ depletion of CD4+ T cells in human skin by zanolimumab
L. S. Villadsen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]ethyl}-methyl-amide]: A novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined Immunodeficient mouse transplants after topical application
N Bhagavathula et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir
F Caspary et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model
WH Boehncke et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Amphiregulin and epidermal hyperplasia - Amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice
N Bhagavathula et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity
V Quekenborn-Trinquet et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α
O Boyman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis:: An in vivo study using the severe combined Immunodeficient mouse-human skin model
SR Raychaudhuri et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model
LS Villadsen et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Epidermal thickness at different body sites: Relationship to age, gender, pigmentation, blood content, skin type and smoking habits
J Sandby-Moller et al.
ACTA DERMATO-VENEREOLOGICA (2003)
Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation
MP Schön et al.
NATURE MEDICINE (2002)
Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: Comparison of antibody to CD11a with cyclosporin A and clobetasol propionate
M Zeigler et al.
LABORATORY INVESTIGATION (2001)
Troglitazone improves psoriasis and normalizes models of proliferative skin disease -: Ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation
CN Ellis et al.
ARCHIVES OF DERMATOLOGY (2000)
Share Paper
